Cognitive impairment after appropriate implantable cardioverter-defibrillator therapy for ventricular fibrillation

Kardiol Pol. 2014;72(2):134-9. doi: 10.5603/KP.a2013.0215. Epub 2013 Aug 30.

Abstract

Background: Short periods of cerebral ischaemia during ventricular defibrillation testing may be associated with neuropsychological impairment. However, the impact of out-of-hospital ventricular fibrillation (VF) converted by implantable cardioverter-defibrillator (ICD) shock on cognitive functioning is unknown.

Aim: To assess the impact of out-of-hospital VF converted by ICD shock on cognitive functioning.

Methods: The study included 52 primary prevention ICD recipients. Patients with a history of stroke or other neurological impairment, previous head injury and individuals unable to see or speak to complete neuropsychological tests were not included.Initially, a Mini-Mental State Examination was performed in all patients and one patient with a result below 24 points was excluded from the study. The cognitive battery consisted of four tests (six measurements): 1) the Digit Span subtest of Wechsler Adult Intelligence Scale-Revised; 2) the Digit Symbol subtest of Wechsler Adult Intelligence Scale-Revised; 3) the Halstead-Reitan Trail-Making Test A and B; and 4) the Ruff Figural Fluency Test.

Results: The mean time from ICD implantation to cognitive assessment was 26 months. During this period, 15 appropriate shocks for VF were observed in seven (14%) patients. The patients with appropriate ICD therapy were significantly worse in two out of the six neuropsychological measurements and had a significantly lower aggregate result. In multivariate linear regression analysis, defibrillation therapy was an independent factor of poor cognitive functioning, along with age and education.

Conclusions: Short periods of out-of-hospital VF converted by ICD are associated with cognitive impairment in the recipients of primary prevention ICD.

MeSH terms

  • Aged
  • Brain Ischemia / etiology*
  • Cognition Disorders / etiology*
  • Death, Sudden, Cardiac / prevention & control*
  • Defibrillators, Implantable / adverse effects*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Outpatients
  • Risk Factors
  • Ventricular Fibrillation / therapy*